Invuity Appoints Scott Flora to Board of Directors
November 21 2017 - 11:20AM
Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company
focused on minimal access surgery, today announced that Scott
D. Flora has been appointed to its Board of Directors, effective
November 21, 2017. Mr. Flora, who brings more than 30 years of
medical device leadership experience, has served as a senior
advisor for Invuity since February 2015.
“We are thrilled to have Scott join our board and we hope to
further leverage his extensive sales and marketing background and
medical device domain expertise as we continue to broaden our
commercial offerings,” said Invuity Chief Executive Officer Philip
Sawyer.
Over the last several decades, Mr. Flora has built a history of
successfully executing new product launches and commercial
expansion, as well as driving business development efforts. Mr.
Flora served as President, Global Business Unit, Surgical Devices
at Covidien for five years. Before that he developed and mentored
strong commercial teams over 20 years at Smith & Nephew, where
he served in various positions, cumulating in his role as President
& General Manager, Orthopedics Reconstruction. Mr. Flora’s was
most recently the CEO of OmniGuide Surgical, where he led the $25
million venture-backed surgical energy business for three years. In
addition, Mr. Flora serves and has served on numerous medical
device company boards, including MAKO Surgical, Conventus
Orthopedics and Agnovos Healthcare.
About Invuity®Invuity, Inc. is a leading
medical technology company focused on developing and marketing
advanced surgical devices to improve the ability of physicians to
perform minimal access surgery through smaller and hidden
incisions. The company's patented Intelligent Photonics™ technology
delivers enhanced visualization which facilitates surgical
precision, efficiency and safety. In addition, the company utilizes
comprehensive strategic marketing programs to create stronger
institutional partnerships. Clinical applications include women's
health, encompassing breast cancer and breast reconstruction
surgery, gynecology and thyroid surgery. Additional applications
include procedures for electrophysiology, spine, orthopedic,
cardiothoracic, and general surgery. Invuity is headquartered in
San Francisco, CA. For more information, visit www.invuity.com.
CONTACT:Company Contact:Jim MackanessChief Financial
OfficerInvuity, Inc.415-655-2129
Investors:Mark KlausnerWestwicke
Partners443-213-0501irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Apr 2024 to May 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From May 2023 to May 2024